Buddy Healthcare Launches COVID-19 Remote Care Solution to Support Hospitals

Buddy HealthcareBuddy Healthcare wants to help hospitals and healthcare professionals in the battle against the COVID-19. BuddyCare virtual care platform can be used for not only symptom tracking, remote monitoring and data collection purposes but also in digitizing secure communication between the individuals/patients and healthcare professionals.

How does the COVID-19 remote care solution work?

1) Hospitals assign the COVID-19 mobile app to the individuals/patients who have either mild symptoms or diagnosed infections without symptoms.

The mobile app contains the following:

  • Accurate, timely information and instructions about COVID-19 published by healthcare authorities/health agencies.
  • A symptom checker that allows app users to report daily symptoms. The symptom checker asks users each day if they have, for example, fewer, coughing, sore throat, or breathing problems.
  • Geographical location and the app user data (gender, age, health), which provides healthcare authorities real life data if the COVID-19 coronavirus starts spreading in certain areas or certain patient profiles.

2) Meanwhile, assigned mobile app users fill symptoms and data to their mobile app; hospitals can monitor, receive alerts, communicate with the patients, and produce reports for analysis.

The hospital monitoring dashboard contains the following functionalities:

  • Care personnel can monitor periodically the symptoms and well-being of at-risk individuals.
  • The dashboard creates alerts when the specified thresholds are exceeded and then can call the individuals/patients to the hospital.
  • Secure messaging allows patients - care personnel interaction during the whole care pathway. Dashboard helps in for example identifying patients at-risk and care personnel can send personalized instructions related to quarantine.
  • The dashboard collects pseudonymized data of the app users for building an overview to support further analysis about symptom development in certain patient profiles or geographical areas.

Buddy Healthcare offers the possibility for healthcare professions or health agencies to check out COVID-19 remote care app. Just send an email to This email address is being protected from spambots. You need JavaScript enabled to view it., and you will be provided with instructions and activation code for login.

"Our modular platform and several years of experience in digital health enabled us to develop the COVID-19 remote care solution only in a few days. We wanted to act as quickly as we could as we have now this sudden high need to identify patients at-risk, expedite access to screening, and medical care," says Jussi Määttä, Buddy Healthcare's CEO

Buddy Healthcare challenges the digital health companies with relevant technologies to support hospitals and health agencies in this battle against COVID-19.

For further information, please visit:
http://www.buddyhealthcare.com

About Buddy Healthcare

At Buddy Healthcare, we help our customers drive a 5-star patient experience. Our dedicated team works day-in and day-out to transform pre- and post-surgical care together with our customers. We want to solve the most significant problems hospitals, clinics and patients are facing in surgeries: patient adherence to treatment, late cancellations and no-shows, administrative work and care quality.

Care personnel doesn’t know how their patients are doing before, and after surgeries, they don’t have tools to monitor patients and receive up-to-date health information, and they spend an extensive amount of time on communications and paperwork. Vice versa, patients don’t want to be any more bystanders in their own treatment. They want to participate in decision-making actively, receive easy-to-follow timely instructions and support and always know what will happen next in their care path.

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Young People Want Trustworthy Mental Hea…

Young people may not be receiving the mental health support they need because of a lack of trust in the smartphone apps that deliver such services, a study suggests. Questions about...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...